特定先天性心脏病诊断影响先天性膈疝结局
该回顾性队列研究利用CDH研究组注册库分析2007-2022年出生的9257例CDH患者,其中2013例(21.7%)合并CHD。CDH+CHD患者院内生存率低于单纯CDH患者(61.6% vs 77.1%,P<0.001),住院时间更长(55 vs 38天,P<0.001)。生存率与低出生体重、较大缺损、使用ECLS和延长插管负相关,且因心脏诊断和CDHSG分期而异。
要点
- CDH合并CHD患者生存率显著低于单纯CDH患者(61.6% vs 77.1%)。
- 低出生体重、大缺损、ECLS使用和延长插管与生存率负相关。
- 单心室解剖总体生存率29.0%,结局随CDHSG分期改善。
核心结论
- CDH+CHD结局与CHD诊断和CDHSG分期相关,需个体化风险分层管理。
研究设计与样本
- 回顾性队列研究,使用CDH研究组注册库分析2007-2022年出生的9257例CDH患者,其中2013例(21.7%)合并CHD。
主要发现
- CDH+CHD患者生存率61.6%,低于CDH-CHD患者的77.1%(P<0.001)。
- CDH+CHD患者住院时间55天,长于CDH-CHD患者的38天(P<0.001)。
- 低出生体重(<2.5 kg)与生存率负相关(OR=0.40,P<0.0001)。
- 较大缺损与生存率负相关(OR=0.46,P<0.0001)。
- 使用ECLS与生存率负相关(OR=0.32,P<0.0001),延长插管亦负相关(OR=0.56,P=0.002)。
关键数值与推荐
- 单心室解剖总体生存率29.0%,结局随CDHSG分期改善。
- 所有CDH+CHD按CDHSG分期的总体生存率:A期97.3%,B期88.4%,C期75.4%,D期52.9%。
临床怎么用
- 对CDH+CHD婴儿应采用个体化、风险分层的管理策略,依据具体心脏诊断和CDHSG分期制定方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Our objective was to assess outcomes for newborns with congenital diaphragmatic hernia (CDH) and congenital heart disease (CHD). SUMMARY BACKGROUND DATA: CDH is a complex malformation often associated with CHD, yet limited data exist on outcomes for infants with both conditions. This study highlights factors associated with survival and how specific cardiac diagnoses shape patient outcomes, with the goal of improving management strategies. METHODS: This retrospective cohort study used the CDH Study Group (CDHSG) registry to analyze patients with CDH+CHD born from 2007-2022. CDHSG stage, cardiac diagnoses, critical care management, and operative details were assessed. The primary outcome was in-hospital survival, with secondary outcomes related to surgical interventions and extracorporeal life support (ECLS). RESULTS: 9,257 CDH patients were identified, with 2,013 (21.7%) having CDH+CHD. Excluding isolated arch and unique anomalies, 483 patients had major CHD and 1,131 had minor CHD. Survival for CDH+CHD patients was lower (61.6%) compared to CDH-CHD patients (77.1%) (P<0.001), with longer hospital stays (55 vs. 38 days, P<0.001). Survival was negatively associated with low birthweight (<2.5 kg) (OR=0.40, P<0.0001), larger defect size (OR=0.46, P<0.0001), use of ECLS (OR=0.32, P<0.0001), and prolonged intubation (OR 0.56, P=0.002). Outcomes varied by cardiac diagnosis and CDHSG stage. For single ventricle anatomy, overall survival is 29.0%, but outcomes improve with CDHSG stage. Overall survival for all CDH+CHD by CDHSG stage is: A (97.3%), B (88.4%), C (75.4%), D (52.9%). CONCLUSION: CDH+CHD outcomes are associated with CHD diagnosis and CDHSG stage. This study highlights the need for an individualized, risk-stratified approach to managing infants with CDH and CHD, moving from a generalized to a more nuanced, lesion-dependent strategy.
引用
- Holden KI, Ebanks AH, Stark RA, et al. Specific Congenital Heart Disease Diagnoses Impact Congenital Diaphragmatic Hernia Outcomes: The Heart of the Matter. Ann Surg. 2025. PMID: 40391440. doi:10.1097/SLA.0000000000006757
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。